Mydecine Innovations Group (MYCO.NE) announced they have signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine. The research will be led by Dr. Matthew Johnson…
Eaton
Revive Therapeutics (RVV.C) announced they are entering into an exclusive license agreement with Puerto Rico Science Technology and Research Trust (PRSTRT) for the intellectual property titled ‘Biologically Active Ganoderma…
NeonMind Biosciences (NEON.C) announced that they have received approval from Health Canada on the product license application for their ‘Mindful Blend’ functional mushroom product. The Mindful Blend functional mushroom…
Cybin (CYBN.NE) announced they are filing a new non-provisional patent application, their 14th patent application. The decision comes after what they called “a favourable international search report” relating to…
Sixth Wave Innovations (SIXW.C) announced that they signed a contract with Rio2 which will see tests continue with Sixth Wave’s patented IXOS purification polymer at Rio2’s Fenix Gold Project in…
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8…
For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which…
Core One Labs (COOL.C) announced that their wholly-owned subsidiaries, Rejuva Mental Health Clinic and Bluejay Mental Health Group, have partnered to assist their patient with completing an application for…
Galaxy Digital Holdings (GLXY.T) announced that Tim Grant will join them as Head of Europe effective August 16. Galaxy Digital is a diversified financial services and investment management company…
Nova Mentis Life Science (NOVA.C) announced it has filed for orphan drug designation with the European Medicines Agency (EMA) for its propriety psilocybin drug to help treat patients with fragile…